0001209191-18-016597.txt : 20180305
0001209191-18-016597.hdr.sgml : 20180305
20180305170345
ACCESSION NUMBER: 0001209191-18-016597
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171115
FILED AS OF DATE: 20180305
DATE AS OF CHANGE: 20180305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ross Michael Jay
CENTRAL INDEX KEY: 0001254452
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38295
FILM NUMBER: 18667088
MAIL ADDRESS:
STREET 1: C/O SV HEALTH INVESTORS, LLC
STREET 2: ONE BOSTON PLC, 201 WASHINGTON ST. #3900
CITY: BOSTON
STATE: MA
ZIP: 02108
FORMER NAME:
FORMER CONFORMED NAME: ROSS MICHAEL JAY
DATE OF NAME CHANGE: 20030715
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arsanis, Inc.
CENTRAL INDEX KEY: 0001501697
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273181608
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 890 WINTER STREET, SUITE 230
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-819-5704
MAIL ADDRESS:
STREET 1: 890 WINTER STREET, SUITE 230
CITY: WALTHAM
STATE: MA
ZIP: 02451
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2017-11-15
2017-12-01
0
0001501697
Arsanis, Inc.
ASNS
0001254452
Ross Michael Jay
C/O SV HEALTH INVESTORS
ONE BOSTON PLACE, SUITE 3900
BOSTON
MA
02108
1
0
0
0
Common Stock (right to buy)
10.00
2017-11-15
4
A
0
25000
0.00
A
2027-11-14
Common Stock
25000
25000
D
Consists of an automatic stock option grant that was made pursuant to the issuer's director compensation policy on November 15, 2017, the date of effectiveness of the registration statement for the issuer's initial public offering. Under the terms of the policy, the Reporting Person received an option to purchase 25,000 shares. Due to a clerical error, the original Form 4 filed on December 1, 2017 erroneously reported an option grant of 7,324 shares. This Amendment to Form 4 is filed solely to correct the share number.
The option becomes exercisable as to 33.3333% of the shares underlying the award on the first anniversary of the date of grant, with the remainder vesting in equal monthly installments until the third anniversary of the date of grant, subject to the Reporting Person's continued service as a director through each applicable vesting date.
/s/ Michael Gray, attorney-in-fact
2018-03-05